Original articles

Analysis of clinical characteristics of adult patients with empyema caused by Streptococcus infection

  • ZHANG Jingyi ,
  • LIU Xu ,
  • YUE Wuriliga ,
  • WANG Mengcan ,
  • CAI Wenlin ,
  • HU Ke
Expand
  • Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Hubei Wuhan 430060, China

Received date: 2026-01-01

  Revised date: 2026-02-15

  Accepted date: 2026-06-18

  Online published: 2026-08-31

Abstract

Objective This study analyzes the clinical characteristics of adult patients with empyema caused by Streptococcus infection, aiming to inform the formulation of diagnostic and treatment strategies as well as prognostic evaluation. Methods A retrospective analysis was conducted on the clinical characteristics of 28 adult patients with empyema confirmed by pleural fluid culture and/or blood culture for Streptococcus at Renmin Hospital of Wuhan University between December 2019 and September 2025. The patients were divided into a group without risk factors (n=8) and a group with risk factors (n=20) based on the presence of comorbidities and/or immunosuppression. The baseline data, clinical manifestations, laboratory and etiological findings, treatment modalities, and clinical outcomes were collected and compared between the two groups. Results A total of 440 patients with empyema were enrolled in this study, among whom empyema caused by Streptococcus infection accounted for 6.4%. CT images of all 28 patients were consistent with the characteristics of pleural effusion, and most patients (19 cases) exhibited loculated effusion accompanied by adjacent pleural thickening. Among them, bilateral empyema was most common (46.43%), followed by right-sided (35.71%) and left-sided (17.86%) empyema. Streptococcus constellatus was the predominant pathogen causing empyema due to Streptococcus infection (50%). Streptococcus intermedius was detected exclusively in the group without risk factors. Other isolated species included Streptococcus anginosus, Streptococcus mitis, Streptococcus pneumoniae, and Streptococcus oralis. No statistically significant differences were observed between the group without risk factors and the group with risk factors in mean age, proportion of patients with fever, or systemic inflammatory markers [white blood cell count, C-reactive protein, procalcitonin (PCT)] (all P>0.05). Five patients in the group without risk factors developed liver function impairment, and the incidence showed a tendency to be higher than that in the group with risk factors (5/8 vs. 3/20 cases, P=0.05). All strains isolated from both groups were susceptible to first-line β-lactam antibiotics, and no significant differences in resistance rates were observed between the two groups (all P>0.05). Regarding clinical outcomes, no significant differences were found in the duration of anti-infective therapy or hospital stay between the two groups. Three patients (3/20, 15.0%) in the group with risk factors died due to empyema and its directly related complications. Among the 28 patients, eight underwent surgical intervention, all of whom improved and were discharged, regardless of risk factor status. Conclusion Streptococcus constellatus is a major pathogen causing adult empyema. Patients without comorbidities and/or immunosuppression have a higher incidence of liver function impairment. In terms of treatment, antimicrobial susceptibility results indicate that first-line β-lactam antibiotics (penicillins/cephalosporins) remain highly effective. However, widespread resistance to clindamycin and other agents warrants attention. For patients with empyema, closed thoracic drainage should be performed as early as possible on the basis of adequate anti-infective therapy.

Cite this article

ZHANG Jingyi , LIU Xu , YUE Wuriliga , WANG Mengcan , CAI Wenlin , HU Ke . Analysis of clinical characteristics of adult patients with empyema caused by Streptococcus infection[J]. Journal of Diagnostics Concepts & Practice, 2026 , 25(04) : 442 -449 . DOI: 10.16150/j.1671-2870.2026.04.007

References

[1] Shen K R, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema[J]. J Thorac Cardiovasc Surg, 2017, 153(6):e129-e146.
[2] Davies H E, Davies R J O, Davies C W H. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010[J]. Thorax, 2010, 65(Suppl 2):ii41-ii53.
[3] Miscia M E, Lauriti G, Di Renzo D, et al. Video-assisted thoracoscopic surgery versus tube thoracostomy with fibrinolytics for treatment of empyema in children: A meta-analysis of randomized controlled studies[J]. Children, 2025, 12(9):1225.
[4] Bobbio A, Bouam S, Frenkiel J, et al. Epidemiology and prognostic factors of pleural empyema[J]. Thorax, 2021, 76(11):1117-1123.
[5] Lisboa T, Waterer G W, Gary Lee Y C. Pleural infection: Changing bacteriology and its implications[J]. Respirolo-gy, 2011, 16(4):598-603.
[6] Ahmed R A, Marrie T J, Huang J Q. Thoracic empyema in patients with community-acquired pneumonia[J]. Am J Med, 2006, 119(10):877-883.
[7] Lin J, Zhang Y, Bao C, et al. The clinical features and management of empyema caused by Streptococcus constellatus[J]. Infect Drug Resist, 2022, 15:6267-6277.
[8] Yang H H, Li M, Yu Q, et al. Empyema caused by Streptococcus constellatus in a patient infected with HIV: A case report and literature review[J]. AIDS Res Ther, 2024, 21(1):2.
[9] Sun J, Tong X, Liu S, et al. Clinical characteristics and mortality risk factors of Streptococcus constellatus infection: A retrospective cohort study of 390 patients[J]. J Infect Public Health, 2026, 19(1):103023.
[10] Kury?ek A, Stasiak M, Kern-Zdanowicz I. Virulence factors of Streptococcus anginosus-a molecular perspective[J]. Front Microbiol, 2022, 13:1025136.
[11] Molloy E M, Cotter P D, Hill C, et al. Streptolysin S-like virulence factors: The continuing SagA[J]. Nat Rev Microbiol, 2011, 9(9):670-681.
[12] Wessels M R. Capsular polysaccharide of group A Streptococcus[J]. Microbiol Spectr, 2019, 7:7.1.01.
[13] Siegman-Igra Y, Azmon Y, Schwartz D. Milleri group Streptococcus: A stepchild in the viridans family[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(9):2453-2459.
[14] Brouwer M C, Tunkel A R, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis[J]. Clin Microbiol Rev, 2010, 23(3):467-492.
[15] Dyrhovden R, Eagan T M, Fl?tten ?, et al. Pleural empye-ma caused by Streptococcus intermedius and Fusobacterium nucleatum: A distinct entity of pleural infections[J]. Clin Infect Dis, 2023, 77(10):1361-1371.
[16] Zohouri M, Zahid A, Silvestre A, et al. A rare case of pyopneumothorax due to Streptococcus intermediusin a pre-viously healthy woman[J]. Case Rep Pulmonol, 2025, 2025:1665286.
[17] Sell R E, Juang D, et al. Streptococcus anginosus Group of bacteria as an underappreciated cause of pneumonia[J]. Open Forum Infect Dis, 2025, 12(10):ofaf538.
[18] Dhainaut J F, Marin N, Mignon A, et al. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes[J]. Crit Care Med, 2001, 29:S42-S47.
[19] Velikova T V, Kabakchieva P P, Assyov YS, et al. Targe-ting inflammatory cytokines to improve type 2 diabetes control[J]. BioMed Res Int, 2021, 2021:7297419.
[20] Tanaka Y. Immunosuppressive mechanisms in diabetes mellitus[J]. Nihon Rinsho, 2008, 66(12):2233-2237.
[21] Al Ghamdi Z M, Boumarah D N, Alshammary S, et al. Pleural empyema as a complication of pyogenic liver abscess: Can the minimum achieve the optimal? A comparison of 3 approaches[J]. Am J Case Rep, 2021, 22:e935169.
[22] Eshghi A, Nejad N H, Mohammadzadeh A, et al. Standard treatment regimen with and without dexamethasone on outcome of children aged 3-7 years with empyema: A randomized double blind clinical trial[J]. Ital J Pediatr, 2025, 51(1):253.
[23] Redden M D, Chin T Y, van Driel M L. Surgical versus non-surgical management for pleural empyema[J]. Cochrane Database Syst Rev, 2017, 2017(3):CD010651.
[24] 王立朋, 罗杰, 李娜, 等. 星座链球菌合并脆弱拟杆菌感染引发菌血症及肝脓肿1例[J]. 中华临床感染病杂志, 2025, 18(4):305-308.
  Wang Lipeng, Luo Jie, Li Na, et al. Co-infection with Streptococcus constellatus and Bacteroides fragilis causing bacteremia and hepatic abscess: A case report[J]. Chin J Clin Infect Dis, 2025, 18(4):305-308.
[25] 中华医学会急诊医学分会, 中国老年医学学会急诊医学分会. 急诊成人社区获得性肺炎医药协同管理抗菌治疗指南[J]. 中华急诊医学杂志, 2025, 34(6):772-781.
  Emergency Medicine Society of Chinese Medical Association, Emergency Medicine Branch of Chinese Geriatric Society. Guideline for antibacterial therapy of adult community-acquired pneumonia in the emergency department under the physician-pharmacist collaborative mana-gement model[J]. Chin J Emerg Med, 2025, 34(6):772-781.
[26] 中国老年医学学会呼吸病学分会. 老年肺炎临床诊断与治疗专家共识(2024年版)[J]. 中华结核和呼吸杂志, 2025, 48(1):18-34.
  Respiratory Branch of Chinese Geriatrics Society. Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly(2024 Edition)[J]. Chin J Tuberc Respir Dis, 2025, 48(1):18-34.
Outlines

/

〈 〉